Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Cereno Scientific’s innovative drug candidate CS585 featured as one of the future antiplatelet strategies in the top-tier Journal of Thrombosis and Haemostasis

Cereno Scientific (Nasdaq First North: CRNO B), a company developing innovative treatments for common and rare cardiovascular disease, today announced that a review article titled “Antiplatelet strategies: past, present, and future” highlighted the company's innovative drug candidate CS585 as a promising future strategy in reducing platelet activity. The review article published in the prestigious Journal of Thrombosis and Haemostasis 20th anniversary issue in December further states that antiplatelet therapy plays a critical role in the prevention and treatment of major cardiovascular

BioStock: Medivir clears key hurdles ahead of phase IIb

While currently conducting a rights issue, Medivir has rapidly progressed the development of the drug candidate fostrox for the treatment of liver cancer. Firstly, they have completed the development of an updated formulation of fostrox suitable for commercial manufacture. Additionally, they have secured agreements for the manufacturing of fostrox GMP substance for clinical trials. The goal is to expedite necessary activities to initiate a pivotal phase IIb study in 2024, with the aim of accelerated approval in 2027.Read the article at biostock.se: https://www.biostock.se/en/2023/12/

Integrum’s MDR certification is completed for the OPRA[TM] Implant System

Mölndal, Sweden – December 15, 2023 — Integrum (publ) (Nasdaq First North Growth Market: INTEG B) today announces that the company has received its final MDR certification, thus finalizing the review process of the company’s products under the new EU medical device regulatory (MDR) framework. The company’s OPRA[TM] Implant System product portfolio has thereby been granted MDR certification and may be freely distributed within the EU for treatment in individuals living with disabilities because of limb loss.Integrum received its MDR certification (Notified Body BSI \2797\) for the last

Historical numbers for 2022 and 2023 recalculated in relation to the new divisional structure

As previously communicated, AFRY X ceased to exist as a division on October 1, 2023 and the existing business units were integrated into the Industrial & Digital Solutions, Infrastructure and Management Consulting divisions. As a consequence, AFRY's reporting structure changed from six to five divisions and below are the restated historical numbers for 2022 and the first three quarters of 2023.Net sales, SEK Q1 Q2 Q3 Q4 FY Q1 Q2 Q3million 2022 2022 2022 2022 2022 2023 2023 2023Infrastructure 2,276 2,305 1,966

AFRY to support Nordic Paper’s strategic investments for sustainable kraft paper production

Nordic Paper, a leading specialty paper producer with its base in Scandinavia, has selected AFRY as its engineering and project management partner for the strategic investment projects at its Bäckhammar mill in Sweden. The projects include a new wood room and a new electrostatic filter.Nordic Paper has decided to invest approximately MSEK 850 to enhance the sustainability performance and competitiveness of the Bäckhammar mill, which produces kraft paper for various applications. An important component of the investment is a new wood room providing for both strategic flexibility in raw

Partial results from Dicot's phase 1 trial to be presented early next year

Press Release: Uppsala, December 15, 2023. Yesterday, the potency drug developer Dicot concluded the clinical part of the SAD, earlier than initially planned. Consequently, the company will be able to report these results already in the January-to-February transition. Results from the second and final part of the phase 1 trial are expected to be communicated in the second quarter of next year, as previously announced.Dicot's phase 1 trial of the potency drug candidate LIB-01 is placebo-controlled and double-blinded, with the primary objective of investigating the safety profile in humans.

Sensys Gatso receives an order from Croatia worth SEK 13.5 million

Sensys Gatso Group, a global leader in traffic safety solutions, has received a purchase order from its local partner in Croatia, Meditronik, for the delivery and maintenance of traffic-safety cameras to the Croatian MOI. The purchase order to Sensys Gatso has a value of EUR 1.2 million, corresponding to SEK 13.5 million.Deliveries of the systems, based on the T-series platform, will take place during the year 2023 - 2026 and the service agreement is for 6 years. The systems will be used for enforcing speed, mainly on state and municipal roads.   “Sensys Gatso and its partner Meditronik

Pricer initiates a cost-savings program which leads to savings of approximately 50 MSEK for long-term competitiveness and profitable growth

Pricer AB ("Pricer" or the "Company") has decided to initiate a cost-savings program, with expected savings of approximately 50 MSEK per year, and plans a restructuring of the organization. The restructuring is estimated to cost approximately 18 MSEK which will be charged to the fourth quarter 2023.During the process, the intangible assets of the company have also been evaluated. A write-down of capitalized development projects of approximately 14 MSEK will thereby be charged to the fourth quarter of 2023. The one-off costs do not affect the covenants in the company's loan agreement. Full

edyoutec signs publisher agreement with MAF for the mobile game King Royale

Press release on December 15, 2023 edyoutec announces that it has signed a publishing agreement with MAF for the mobile game King Royale. This initially means that Edyoutec, together with MAF, begins a test period with the aim of increasing the monetization of the game. MAF has the opportunity to expose King Royale to its user base of 50 million monthly users.After a series of successful game updates, King Royale has achieved stronger KPIs and is ready to focus on monetization to further strengthen its presence in the gaming market. The agreement means that MAF markets and evaluates

COVID-19 infection alters gene transcription of olfactory mucosal cells in Alzheimer's disease

A new study identifies alterations in the transcriptomic signatures in human olfactory mucosal cells of individuals with Alzheimer's disease following SARS-CoV-2 infection, potentially contributing to exacerbated COVID-19 outcomes. The study was conducted at the University of Eastern Finland in collaboration with the University of Helsinki and published in Journal of Neuroinflammation. The study was prompted by concerns about the impact of COVID-19 on individuals with pre-existing conditions such as Alzheimer’s disease (AD). Olfactory dysfunction, characterized by an impaired sense of

MyFirstApp: Set to Launch Evolear Beta as Planned

Stockholm, Sweden – 2024-12-15MyFirstApp Sweden AB, aspiring to be a leader in AI-based educational technology, proudly announces that they are in the final stages of development for the beta launch of Evolear. This innovative platform, set to launch before Christmas, offers a unique and personalized learning experience to children worldwide. Evolear – A new era in Ed-TechEvolear is a groundbreaking AI-based platform, designed to enhance learning through individualized pedagogy. It dynamically adapts to each student's abilities and progress, transforming the traditional educational

Repurchase of Outokumpu’s own shares

Outokumpu OyjStock exchange releaseDecember 15, 2023, at 9.30 am EETRepurchase of Outokumpu’s own shares On December 14, 2023, Outokumpu has completed repurchases its own shares as follows (ISIN FI0009002422): +-------+----------------+------------------------------------+----------------+|Trading|Number of shares|Weighted average price / share, EUR*|Total cost, EUR*||venue | | | |+-------+----------------+------------------------------------+----------------+|CEUX |82,890 |4.4611

Announcement of a change in shareholding according to Chapter 9, Section 10 of the Finnish Securities Market Act

Announcement of a change in shareholding according to Chapter 9, Section 10 of the Finnish Securities Market Act Musti Group plc                         Stock Exchange Release                                         15 December 2023 at 9.30am Musti Group plc (the “Company”) has on 14 December 2023 received a notification in accordance with the Chapter 9, Section 5 of the Finnish Securities Markets Act from The Capital Group Companies, Inc (”CGC”), according to which CGC’s holding of the shares and votes of the Company decreased below the threshold of 5 percent on 13 December 2023.

Sectra’s six-month interim report 2023/2024: Strong performance in all operating areas

Press release – Linköping, December 15, 2023 – Customers’ use of international medical imaging IT and cybersecurity company Sectra’s  (STO: SECT B) products and services for medical imaging IT and secure communications is increasing. All operating areas reported their highest sales to date for a single quarter as well as their best operating profit for a second quarter. The transition to service sales is progressing, and recurring revenue is continuing to grow quickly. Strong growth, favorable currency movements and a turnaround in secure communications helped offset the

Sivers Semiconductors granted €1.2 million EU grant for design of 6G chip

Sivers Semiconductors AB (publ) (“Sivers”) today announces that its business unit, Sivers Wireless, has been granted €1.2 million (approx. 14 MSEK) EU Grant from HORIZON Europe as part of a larger consortium, to design millimeter Wave (mmWave) building blocks for next-generation 6G technology. The grant will cover 90% of Sivers funding for the 6G project and run for 3.5 years, 50% of the funding will be paid out before year end by EU.Sivers Wireless will be responsible for the below-100-GHz frontend design, and in addition, Sivers will also co-design a wideband off-chip antenna with the

Esmaeilzadeh Holding publishes net asset value as of 30 November 2023

As of 30 November 2023, the net asset value for Esmaeilzadeh Holding AB (publ) was SEK 7.19 billion (SEK 7.71 billion as of 31 October 2023), corresponding to a net asset value per share of SEK 9,327 (SEK 9,996 as of 31 October 2023). For further information, please contact: Saeid Esmaeilzadeh, CEO and founder saeid@ehab.group Nils Fredrik Lagerstrand, General Counsel & Deputy CEO +46 720 90 26 99, nilsfredrik@ehab.group The information was submitted for publication, through the agency of the contact persons set out above, at 08.00 CET on 15 December 2023. About

Peab builds new swimming pool facility in Leknes

Peab has been commissioned to build a new swimming pool facility in Leknes. The customer is Vestvågøy Municipality and the contract is worth NOK 262 million.The swimming pool facility project entails an addition of 2,500 m2 as well as rebuilding the existing building of 2,300 m2. The new addition will contain a competition pool, training and therapy pool, diving tower, slide and a wellness area with a jacuzzi, cold pool and sauna. A new cloakroom and lobby will built into the original swimming pool building from 1974. “The new swimming pool facility will be a community arena with special

Christmas greetings from Quickbit’s CEO Daniel Sonesson

Quickbit’s CEO, Daniel Sonesson, sends a video-recorded Christmas greeting in which he summarizes the year 2023 and expresses his enthusiasm for advancing Quickbit into its next phase in 2024 - as Quickbit 2.0.   Watch the video in this link:  https://youtu.be/KqNPHNnXJdY   For further information, please contact: Daniel Sonesson, CEO  + 46 73 530 30 25ir@quickbit.com    ------------------------------------ Quickbit is a Swedish fintech company founded in 2016 with the goal of making the integration of cryptocurrencies into the everyday lives of people and

Notice of extraordinary general meeting in HANZA AB (publ)

The shareholders in HANZA AB (publ) reg. no. 556748–8399 (“HANZA”) are hereby convened to the extraordinary general meeting on Monday den 8 January 2024 at 17.00 at Torshamnsgatan 35, Kista.Notice of participation Shareholders who wish to participate at the extraordinary general meeting shall: · be registered in the share register kept by Euroclear Sweden AB on the record date of the general meeting, i.e., on Thursday 28 December 2023, · notify their attendance to HANZA no later than Wednesday 3 January 2024, under the address Torshamnsgatan 35, 164 40 Kista or via e-mail to lars.

Musti Group’s Annual Report for the financial year 2023 has been published

Musti Group plc                                                             Stock Exchange Release    15 December 2023 at 9:00 a.m. Musti Group’s Annual Report for the financial year 2023 has been published Musti Group has today published its Annual Report for October 2022 – September 2023 in Finnish and in English. The report comprises Musti Group's Financial Statements, the Board of Directors’ Report, Corporate Governance Statement and Remuneration Report for the financial year 2023. The Financial Statements section comprises the Consolidated Financial Statements, the Parent

The H&M group’s sales development for full-year 2023 including the fourth quarter

Full-yearFor the 2023 financial year, covering the period 1 December 2022 – 30 November 2023, net sales increased by 6 percent to SEK 236,014* m (223,553), compared with 2022. Excluding Russia and Belarus the increase was 8 percent in SEK and 1 percent in local currencies. Fourth quarterNet sales in the period 1 September 2023 - 30 November 2023 were flat compared with the corresponding quarter last year and amounted to SEK 62,629* m (62,433). Excluding Russia and Belarus the increase was 3 percent in SEK and decreased by 1 percent in local currencies. In total, the H&M group’s net

Transaction in Own Shares

    15 December 2023 Vesuvius plc Share Buyback Programme – Transactions in Own Securities   Vesuvius plc (the "Company") announces that it has purchased the following number of its Ordinary Shares of 10p each from Jefferies International Limited (the “Broker”), pursuant to the terms of its Share Buyback Programme announced on 4 December 2023:   +---------------------------------------------------------------+----------+|Date of purchase: |14/12/2023|+----------------------------------------------------------

Proposal of SRV Group Plc’s Board of Directors to the 2024 Annual General Meeting concerning the appointment of the auditor

SRV GROUP PLC       STOCK EXCHANGE RELEASE   15 DECEMBER 2023     09:00 EET Proposal of SRV Group Plc’s Board of Directors to the 2024 Annual General Meeting concerning the appointment of the auditor Following the recommendation of the Audit Committee, the Board of Directors of SRV Group Plc proposes to the Annual General Meeting scheduled for 25 March 2024 that, based on the competitive tendering of the audit, the audit firm PricewaterhouseCoopers Oy be appointed as the company’s auditor for the 2024 financial year. If PricewaterhouseCoopers Oy is selected as the auditor of the SRV

Stora Enso shares converted

STORA ENSO OYJ STOCK EXCHANGE RELEASE 15 December 2023 at 9:00 EETDuring the 1–30 November 2023 conversion period there were six conversions and a total of 498 A shares were converted into R shares. The shares were recorded in the Finnish trade register today, 15 December 2023, and trading in the new R shares will start on 16 December 2023.Breakdown of shares after conversion:A shares     176,230,911R shares     612,389,076Total           788,619,987Each A share and every ten R shares carry one vote. The total amount of votes after the conversion is at least 237,469,818.For

There are no items matching the current filter
There are no more items matching the current filter
Back to top